SCL | Jotup

Nanox Announces Collaboration with AhealthZ and SCL Science to Enter South Korean Market

Retrieved on:

Tuesday, April 9, 2024

Diagnosis, X-ray, LTD, Cardiology, Patient, Science, Radiology, SCL, Department of Tourism (Philippines), NANO, Teleradiology, ARC, Marketing, Medical device

PETAH TIKVA, Israel, April 09, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced a new collaboration to advance the Nanox.ARC 3D imaging system and Nanox artificial intelligence (AI) solutions in Korea with AhealthZ – a distributor of healthcare services and devices – and SCL Science, AhealthZ’s affiliated company and subsidiary of global healthcare group SCL (Seoul Clinical Laboratories).

Key Points:

Under the collaboration, AhealthZ plans to assist Nanox in efforts to secure local authorizations and licenses to enable the importation, marketing and sales of the Nanox.ARC in South Korea.
The Nanox.ARC is a digital tomosynthesis system that uses multiple sources of X-rays to produce a three-dimensional, tomographic images.
The collaboration will also include SCL Science integrating Nanox’s AI solutions in remote image analysis and other operations.
“We are excited to work with AhealthZ and SCL Science to bring our comprehensive medical imaging solutions to South Korea, a country of over 51 million people and one of the world’s most advanced technological markets,” said Erez Meltzer, Nanox Chief Executive Officer.

Stepan to Announce First Quarter 2024 Results on April 30, 2024

Retrieved on:

Tuesday, April 9, 2024

PIN, Tax, Conference, Adhesive, Stepan Company, Form, Webcast, Knowledge, News, Elastomer, Acquisition, Transport, SCL, Accident, Coating, Intellectual property, Instability

NORTHBROOK, Ill., April 9, 2024 /PRNewswire/ -- Stepan Company (NYSE: SCL) will issue its first quarter 2024 earnings results on Tuesday, April 30, 2024 at approximately 7:00 a.m.

Key Points:

NORTHBROOK, Ill., April 9, 2024 /PRNewswire/ -- Stepan Company (NYSE: SCL) will issue its first quarter 2024 earnings results on Tuesday, April 30, 2024 at approximately 7:00 a.m.
Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries.
Headquartered in Northbrook, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia.
As a result, Stepan Company's actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements.

After a successful Series B fundraising round from Seoul Clinical Laboratories (Korea), Standard Foods and and AWS cloud services representative GrandTech C.G. Systems (Taiwan), H2U secured over 10 million USD in funds

Retrieved on:

Sunday, February 25, 2024

TAIPEI, Taiwan, Feb. 24, 2024 /PRNewswire/ -- Taiwan's leading digital health brand, H2U, ushered in the lunar new year with exciting news. Entities such as Korea's largest medical laboratory, Seoul Clinical Laboratories (SCL), Taiwan's biggest food company, Standard Foods, the leading protein and antibody reagent innovator and manufacturer, Leadgene Biomedical, and AWS cloud services representative, GrandTech C.G. Systems, have enthusiastically joined H2U's current round of fundraising (Series B) before the lunar new year, raising over 10 million USD in funds. Prior to this round, H2U had already secured investments from reputable institutional investors, including Foxconn Technology, ADATA, TOPCO, UDN, WeLeader Bio, Flight International, Wondercise, and Sparklabs.

Key Points:

H2U is expanding its reach to South Korea through a SaaS-based digital health check platform and a closed-loop post-check health management program.
TAIPEI, Taiwan, Feb. 24, 2024 /PRNewswire/ -- Taiwan's leading digital health brand, H2U, ushered in the lunar new year with exciting news.
Entities such as Korea's largest medical laboratory, Seoul Clinical Laboratories (SCL), Taiwan's biggest food company, Standard Foods, the leading protein and antibody reagent innovator and manufacturer, Leadgene Biomedical, and AWS cloud services representative, GrandTech C.G.
Systems, have enthusiastically joined H2U's current round of fundraising (Series B) before the lunar new year, raising over 10 million USD in funds.

After a successful Series B fundraising round from Seoul Clinical Laboratories (Korea), Standard Foods and and AWS cloud services representative GrandTech C.G. Systems (Taiwan), H2U secured over 10 million USD in funds

Retrieved on:

Sunday, February 25, 2024

TAIPEI, Taiwan, Feb. 25, 2024 /PRNewswire/ -- Taiwan's leading digital health brand, H2U, ushered in the lunar new year with exciting news. Entities such as Korea's largest medical laboratory, Seoul Clinical Laboratories (SCL), Taiwan's biggest food company, Standard Foods, the leading protein and antibody reagent innovator and manufacturer, Leadgene Biomedical, and AWS cloud services representative, GrandTech C.G. Systems, have enthusiastically joined H2U's current round of fundraising (Series B) before the lunar new year, raising over 10 million USD in funds. Prior to this round, H2U had already secured investments from reputable institutional investors, including Foxconn Technology, ADATA, TOPCO, UDN, WeLeader Bio, Flight International, Wondercise, and Sparklabs.

Key Points:

H2U is expanding its reach to South Korea through a SaaS-based digital health check platform and a closed-loop post-check health management program.
TAIPEI, Taiwan, Feb. 25, 2024 /PRNewswire/ -- Taiwan's leading digital health brand, H2U, ushered in the lunar new year with exciting news.
Entities such as Korea's largest medical laboratory, Seoul Clinical Laboratories (SCL), Taiwan's biggest food company, Standard Foods, the leading protein and antibody reagent innovator and manufacturer, Leadgene Biomedical, and AWS cloud services representative, GrandTech C.G.
Systems, have enthusiastically joined H2U's current round of fundraising (Series B) before the lunar new year, raising over 10 million USD in funds.

Stepan Company Announces Appointment of New Director

Retrieved on:

Thursday, February 15, 2024

Dow Chemical Company, Senior, Adhesive, Risk management, Retirement, Elastomer, Global Operations, Coating, SCL, Stepan Company

NORTHBROOK, Ill., Feb. 15, 2024 /PRNewswire/ -- Stepan Company (NYSE: SCL) announced today the appointment of Susan M. Lewis as a Director of Stepan, effective on February 15, 2024.

Key Points:

NORTHBROOK, Ill., Feb. 15, 2024 /PRNewswire/ -- Stepan Company (NYSE: SCL) announced today the appointment of Susan M. Lewis as a Director of Stepan, effective on February 15, 2024.
"Susan brings to our Board of Directors extensive supply chain experience in the chemical manufacturing industry and an understanding of the agricultural industry, a key market for Stepan," said F. Quinn Stepan, Jr., Chairman of the Board of Stepan.
Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries.
For more information about Stepan Company please visit the Company online at www.stepan.com .

Stepan to Announce Fourth Quarter and Full Year 2023 Results on February 20, 2024

Retrieved on:

Tuesday, January 30, 2024

Instability, Adhesive, Knowledge, Accident, SCL, Coating, Elastomer, Form, Tax, Stepan Company, Acquisition, Conference, PIN, Intellectual property, Webcast, Transport, News

NORTHBROOK, Ill., Jan. 30, 2024 /PRNewswire/ -- Stepan Company (NYSE: SCL) will issue its fourth quarter and full year 2023 earnings results on Tuesday, February 20, 2024 at approximately 7:00 a.m.

Key Points:

NORTHBROOK, Ill., Jan. 30, 2024 /PRNewswire/ -- Stepan Company (NYSE: SCL) will issue its fourth quarter and full year 2023 earnings results on Tuesday, February 20, 2024 at approximately 7:00 a.m.
The call will be hosted by Scott R. Behrens, President and Chief Executive Officer, and Luis E. Rojo, Vice President and Chief Financial Officer.
Headquartered in Northbrook, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia.
As a result, Stepan Company's actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements.

CSX and BRS Reach Second Agreement on Paid Sick Leave

Retrieved on:

Wednesday, October 25, 2023

IBEW, CSX Corporation, BRS, Brotherhood of Railroad Signalmen, CSX, L&N, IAM, BRC, Brotherhood, SCL, TD, NCFO, Sick leave, Health insurance, Nursing

JACKSONVILLE, Fla., Oct. 25, 2023 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) is announcing the ratification of a paid sick leave agreement covering approximately 200 employees represented by the Brotherhood of Railroad Signalmen (BRS) on the company’s L&N property.

Key Points:

JACKSONVILLE, Fla., Oct. 25, 2023 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) is announcing the ratification of a paid sick leave agreement covering approximately 200 employees represented by the Brotherhood of Railroad Signalmen (BRS) on the company’s L&N property.
The ratification follows another recent agreement with the BRS covering nearly 400 employees on the SCL property.
CSX continues to build on series of successful negotiations with various railroad unions to provide paid sick leave.
This includes agreements reached earlier this year with the BMWED, BRC, SMART-TD, IAM, NCFO and IBEW unions, providing paid sick leave for thousands of railroad workers.

Rhizome Raises $2.5 Million, Launches to Ensure a Resilient Grid

Retrieved on:

Tuesday, October 24, 2023

With ongoing engagements with several major electric utilities, Rhizome is primed to make the electric grid safe, reliable, and resilient by forecasting climate impacts on utility infrastructure and optimizing grid investments.

Key Points:

With ongoing engagements with several major electric utilities, Rhizome is primed to make the electric grid safe, reliable, and resilient by forecasting climate impacts on utility infrastructure and optimizing grid investments.
“As climate change escalates and its impacts become more devastating, we must be precise and decisive in modernizing the grid,” said Rhizome co-founder and CEO Mishal Thadani.
“Rhizome’s veteran team is focused on helping utilities and regulators make the grid more resilient without significant cost increases for communities.
Rhizome pairs resilience research from national labs with infrastructure data and proprietary machine learning to place a “value of resilience” on every proposed grid investment.

CSX and BRS Reach Agreement on Paid Sick Leave

Retrieved on:

Thursday, October 19, 2023

Rail transport, IBEW, Signalman, Workforce, CSX Corporation, Brotherhood of Railroad Signalmen, CSX, IAM, BRC, Brotherhood, SCL, TD, NCFO, Sick leave, Health insurance

JACKSONVILLE, Fla., Oct. 19, 2023 (GLOBE NEWSWIRE) -- CSX Corporation (NASDAQ: CSX) is pleased to announce the ratification of a paid sick leave agreement with the SCL property for the Brotherhood of Railroad Signalmen covering nearly 400 employees.

Key Points:

JACKSONVILLE, Fla., Oct. 19, 2023 (GLOBE NEWSWIRE) -- CSX Corporation (NASDAQ: CSX) is pleased to announce the ratification of a paid sick leave agreement with the SCL property for the Brotherhood of Railroad Signalmen covering nearly 400 employees.
The agreement underscores CSX's commitment to the welfare and well-being of its workforce.
It provides a sick leave package that ensures employees can take necessary time off from work to recover from illness without worrying about their financial stability.
This includes agreements reached earlier this year with the BMWED, BRC, SMART-TD, IAM, NCFO and IBEW unions, providing paid sick leave for thousands of railroad workers across the country.

Stepan to Announce Third Quarter 2023 Results on October 18, 2023

Retrieved on:

Tuesday, October 3, 2023

NORTHBROOK, Ill., Oct. 3, 2023 /PRNewswire/ -- Stepan Company (NYSE: SCL) will issue its third quarter 2023 earnings results on Wednesday, October 18, 2023 at approximately 7:00 am ET (6:00 am CT).

Key Points:

NORTHBROOK, Ill., Oct. 3, 2023 /PRNewswire/ -- Stepan Company (NYSE: SCL) will issue its third quarter 2023 earnings results on Wednesday, October 18, 2023 at approximately 7:00 am ET (6:00 am CT).
Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries.
Headquartered in Northbrook, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia.
As a result, Stepan Company's actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements.